Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice (Q44567461)

4 December 2017

title

Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice (English)

1 reference

4 December 2017

9

1 reference

4 December 2017

Kaido Kurrikoff

3

0 references

Toshimitsu Matsui

object named as

Toshimitsu Matsui

7

0 references

Sirli Raud

5

object named as

Sirli Raud

1 reference

4 December 2017

10

Eero Vasar

1 reference

4 December 2017

Kertu Rünkorg

1

1 reference

4 December 2017

Alar Veraksits

2

1 reference

4 December 2017

Hendrik Luuk

4

1 reference

4 December 2017

Urho Abramov

6

1 reference

4 December 2017

Michel Bourin

8

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Behavioural Brain Research

4 December 2017

published in

1 reference

4 December 2017

volume

144

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

125-135

1 reference

Effects of test conditions on the outcome of place conditioning with morphine and naltrexone in mice

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Central mechanisms of pain modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Cholecystokinin Receptors in the Brain: Characterization and Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Involvement of the opioid system in the anxiolytic effect of diazepam in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2803%2900070-6

7 January 2021

10.1016/S0166-4328(03)00070-6

Identifiers

DOI

1 reference

4 December 2017

1 reference